Management of Lower Urinary Tract Dysfunction in Patients with Neurological Disorders

다국어 초록 (Multilingual Abstract)

The proper performance of the lower urinary tract is dependent on an intact neural innervation of the individual structures involved. Therefore, any congenital neurological anomalies, diseases, or lesions of the central, peripheral, or autonomic nervous systems can result in lower urinary tract symptoms. Lower urinary tract dysfunction (LUTD) secondary to neurological disorders can significantly reduce quality of life (QoL) and may also give rise to serious complications and psychological and social sequelae. The goals of management of LUTD in patients with neurological disorders are to prevent serious complications and to improve the patient’s QoL. Understanding the physiology and pathophysiology of micturition is critical to selecting appropriate treatment options. This article provides an overview of the clinical characteristics, diagnosis, and management of LUTD in patients with certain central and peripheral neuropathies and common lesions.

참고문헌 (Reference)

1 신지철, "척수손상 환자에서 증상성 요로감염 시 소변 균주와 항생제 감수성의 변화" 대한재활의학회 32 (32): 38-44, 2008

2 박정수, "척수손상 환자에서 상부요로합병증을 유발하는 위험인자에 대한 분석: 비디오 요역동학검사 결과를 중심으로" 대한비뇨기과학회 46 (46): 943-949, 2005

3 권택민, "신경인성 방광 환아에서 상부요로계 손상의 위험 인자 분석" 대한비뇨기과학회 50 (50): 1248-1252, 2009

4 한수정, "만성 척수 손상 환자의 요로 감염 위험 인자" 대한재활의학회 29 (29): 181-186, 2005

5 Araki I, "Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms" 164 : 1640-1643, 2000

6 Ku JH, "Voiding diary for the evaluation of urinary incontinence and lower urinary tract symptoms: prospective assessment of patient compliance and burden" 23 : 331-335, 2004

7 Marinkovic SP, "Voiding and sexual dysfunction after cerebrovascular accidents" 165 : 359-370, 2001

8 Sakakibara R, "Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy" 71 : 600-606, 2001

9 Gormley EA, "Urologic complications of the neurogenic bladder" 37 : 601-607, 2010

10 Swaminath PV, "Urogenital symptoms in Parkinson's disease and multiple system atrophy-Parkinsonism: at onset and later" 58 : 86-90, 2010

11 Watanabe T, "Urodynamics of spinal cord injury" 23 : 459-473, 1996

12 Bansal R, "Urodynamic profile of diabetic patients with lower urinary tract symptoms: association of diabetic cystopathy with autonomic and peripheral neuropathy" 77 : 699-705, 2011

13 Kaplan SA, "Urodynamic findings in patients with diabetic cystopathy" 153 : 342-344, 1995

14 Dib PT, "Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms" 80 : 378-382, 2008

15 Bloch F, "Urodynamic analysis in multiple system atrophy: characterisation of detrusor-sphincter dyssynergia" 257 : 1986-1991, 2010

16 Sauerwein D, "Urinary tract infection in patients with neurogenic bladder dysfunction" 19 : 592-597, 2002

17 Uchiyama T, "Urinary dysfunction in early and untreated Parkinson's disease" 82 : 1382-1386, 2011

18 Bright E, "Urinary diaries: evidence for the development and validation of diary content, format, and duration" 30 : 348-352, 2011

19 Katsumi HK, "Urethral versus suprapubic catheter: choosing the best bladder management for male spinal cord injury patients with indwelling catheters" 48 : 325-329, 2010

20 de Jong TP, "Treatment of the neurogenic bladder in spina bifida" 23 : 889-896, 2008

21 Abrams P, "The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society" 21 : 167-178, 2002

22 Biers SM, "The past, present and future of augmentation cystoplasty" 109 : 1280-1293, 2012

23 Ku JH, "The management of neurogenic bladder and quality of life in spinal cord injury" 98 : 739-745, 2006

24 Van Meel TD, "The effect of intravesical oxybutynin on the ice water test and on electrical perception thresholds in patients with neurogenic detrusor overactivity" 29 : 391-394, 2010

25 Cameron AP, "Systematic review of urological followup after spinal cord injury" 187 : 391-397, 2012

26 Cruz CD, "Spinal cord injury and bladder dysfunction: new ideas about an old problem" 11 : 214-234, 2011

27 정성진, "Spinal Cord/Brain Injury and the Neurogenic Bladder" Elsevier 37 : 537-+, 201011

28 Krassioukov A, "Spinal Cord Injury Rehabilitation Evidence Research Team. A systematic review of the management of autonomic dysreflexia after spinal cord injury" 90 : 682-695, 2009

29 Sakakibara R, "Sphincter EMG as a diagnostic tool in autonomic disorders" 19 : 20-31, 2009

30 Gilman S, "Second consensus statement on the diagnosis of multiple system atrophy" 71 : 670-676, 2008

31 Fowler CJ, "Review of neurologic diseases for the urologist" 37 : 517-526, 2010

32 Dromerick AW, "Relation of postvoid residual to urinary tract infection during stroke rehabilitation" 84 : 1369-1372, 2003

33 Stöhrer M, "Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study" 51 : 235-242, 2007

34 McGuire EJ, "Prognostic value of urodynamic testing in myelodysplastic patients. 1981" 167 (167): 1049-1053, 2002

35 Nakayama H, "Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study" 28 : 58-62, 1997

36 Köllensperger M, "Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry" 25 : 2604-2612, 2010

37 Li WJ, "Poly(ADP-ribose) polymerase is involved in the development of diabetic cystopathy via regulation of nuclear factor kappa B" 77 : 1265-1261, 2011

38 Cameron AP, "Pharmacologic therapy for the neurogenic bladder" 37 : 495-506, 2010

39 Kennelly MJ, "Overactive bladder: pharmacologic treatments in the neurogenic population" 10 : 182-191, 2008

40 Wyndaele JJ, "Neurologic urinary incontinence" 29 : 159-164, 2010

41 Sahai A, "Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management" 12 : 404-412, 2011

42 Benevento BT, "Neurogenic bladder, neurogenic bowel, and sexual dysfunction in people with spinal cord injury" 82 : 601-612, 2002

43 Horstmann M, "Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage" 25 : 441-445, 2006

44 Dorsher PT, "Neurogenic bladder" 2012 : 816274-, 2012

45 Yoshimura N, "Neural control of the lower urinary tract" 4 : 111-125, 1997

46 Wang P, "Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins" 273 : 959-966, 1995

47 Wenning GK, "Multiple system atrophy" 3 : 93-103, 2004

48 Sakakibara R, "Micturitional disturbance after acute hemispheric stroke: analysis of the lesion site by CT and MRI" 137 : 47-56, 1996

49 Gulur DM, "Management of overactive bladder" 7 : 572-582, 2010

50 Mourtzinos A, "Management goals for the spina bifida neurogenic bladder: a review from infancy to adulthood" 37 : 527-535, 2010

51 Austin JC, "Long-term risks of bladder augmentation in pediatric patients" 18 : 408-412, 2008

52 Rabchevsky AG, "Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury" 8 : 274-282, 2011

53 Winder A, "Intermittent self-catheterisation" 98 : 50-, 2002

54 de Groat WC, "Integrative control of the lower urinary tract: preclinical perspective" 147 (147): 25-40, 2006

55 Ito T, "Incomplete emptying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it?" 21 : 816-823, 2006

56 Kong KH, "Incidence and outcome of poststroke urinary retention: a prospective study" 81 : 1464-1467, 2000

57 Koch T, "Identifying strategies for managing urinary incontinence with women who have multiple sclerosis" 8 : 550-559, 1999

58 Oh SJ, "Health-related quality of life of patients using clean intermittent catheterization for neurogenic bladder secondary to spinal cord injury" ELSEVIER SCIENCE INC 65 : 306-310, 2005

59 Pramstaller PP, "Fowler CJ. Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy" 58 : 618-621, 1995

60 Kelly CE, "Evaluation of voiding dysfunction and measurement of bladder volume" 6 (6): 32-37, 2004

61 Scales CD Jr, "Evaluating outcomes of enterocystoplasty in patients with spina bifida: a review of the literature" 180 : 2323-2329, 2008

62 Cartwright PC, "Efficacy and safety of transdermal and oral oxybutynin in children with neurogenic detrusor overactivity" 182 : 1548-1554, 2009

63 Kennelly MJ, "Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study" 74 : 741-745, 2009

64 Cruz F, "Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial" 60 : 742-750, 2011

65 Amend B, "Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects" 53 : 1021-1028, 2008

66 Oh SJ, "Effect of a 'centralized intensive education system' for clean intermittent self-catheterization in patients with voiding dysfunction who start catheterization for the first time" BLACKWELL PUBLISHING 13 : 905-909, 2006

67 Stöhrer M, "EAU guidelines on neurogenic lower urinary tract dysfunction" 56 : 81-88, 2009

68 Bacsu CD, "Diagnosing detrusor sphincter dyssynergia in the neurological patient" 109 (109): 31-34, 2012

69 Daneshgari F, "Diabetic uropathy" 26 : 182-185, 2006

70 Li WJ, "Diabetic cystopathy is associated with PARP/JNK/ mitochondrial apoptotic pathway-mediated bladder apoptosis" 29 : 1332-1337, 2010

71 Daneshgari F, "Diabetic bladder dysfunction: current translational knowledge" 182 (182): 18-26, 2009

72 Bright E, "Developing a validated urinary diary: phase 1" 31 : 625-633, 2012

73 Hyman MJ, "Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings" 166 : 550-552, 2001

74 Wyndaele JJ, "Correlation between clinical neurological data and urodynamic function in spinal cord injured patients" 35 : 213-216, 1997

75 Feifer A, "Contemporary role of suprapubic cystostomy in treatment of neuropathic bladder dysfunction in spinal cord injured patients" 27 : 475-479, 2008

76 Mangera A, "Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)" 60 : 784-795, 2011

77 Aslan AR, "Conservative management in neurogenic bladder dysfunction" 12 : 473-477, 2002

78 Bennett N, "Can higher doses of oxybutynin improve efficacy in neurogenic bladder?" 171 (171): 749-751, 2004

79 Duthie JB, "Botulinum toxin injections for adults with overactive bladder syndrome" (12) : 005493-, 2011

80 Consortium for Spinal Cord Medicine, "Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers" 29 : 527-573, 2006

81 Gomez CS, "Bladder dysfunction in patients with diabetes" 12 : 419-426, 2011

82 Campeau L, "Bladder dysfunction and parkinsonism: current pathophysiological understanding and management strategies" 12 : 396-403, 2011

83 Wiener JS, "Bladder augmentation versus urinary diversion in patients with spina bifida in the United States" 186 : 161-165, 2011

84 Stein R, "Bladder augmentation and urinary diversion in patients with neurogenic bladder: surgical considerations" 8 : 153-161, 2012

85 Weld KJ, "Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury" 55 : 490-494, 2000

86 Michel MC, "Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate" 147 (147): 88-119, 2006

87 Burney TL, "Acute cerebrovascular accident and lower urinary tract dysfunction: a prospective correlation of the site of brain injury with urodynamic findings" 156 : 1748-1750, 1996

88 Abrams P, "A proposed guideline for the urological management of patients with spinal cord injury" 101 : 989-994, 2008